Biomarker Profiling in Alzheimer’s Disease Research

Neurodegenerative disease processes involve a limited sample material (CSF) and an expanding number of biomarkers. This white paper highlights how reproducible and sensitive multiplexed assay systems, such as Luminex xMAP Technology, are ideal solutions for biomarker profiling in Alzheimer’s disease research. They can simultaneously interrogate multiple protein targets per sample, across a large number of samples, using small sample volumes.